23andMe, genetic testing
Me is to cut 200 jobs in the wake of declining revenues. This company expects a proposed retructuring, affecting 40% of its ...
Me Holding Co.’s stock turned down early Tuesday, after the DNA-testing company reported its latest quarterly loss, shedding ...
The CEO of 23andMe said there was "substantial doubt" that the company could continue to operate and said 40 percent of its ...
Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to ...
Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...
The company said it is evaluating strategic alternatives, including licensing agreements and asset sales, for its therapies ...
Genetic-testing lab 23andMe plans to cut its workforce by 40% and end its therapeutics program in an effort to cut costs, the ...
23andMe on Tuesday reported that second-quarter revenue fell to $44.1 million from $50 million a year earlier. The ...
The genetic testing company 23andMe announced it was laying off more than 200 employees, or roughly 40% of its entire ...
In this photo illustration, a 23andMe logo seen displayed on a smartphone and in the background. The company announced ...
The genealogy company’s CEO announced over 200 employees will be let go and it will also shutter its drug-development arm. I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback